Maintenance Zanzalintinib With Etoposide After HDCT in GCT
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Exelixis
Related studies linked through entity extraction aliases.
Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
- Status
- RECRUITING
- Phase
- PHASE2
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
- Status
- RECRUITING
- Phase
- PHASE1
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
- Status
- RECRUITING
- Phase
- PHASE2
Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
- Status
- RECRUITING
- Phase
- PHASE2
A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of XB010 in Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)
- Status
- TERMINATED
- Phase
- PHASE1
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3